Silvia Casagrande

7PUBLICATIONS
38CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)AutoimmunityNeurology and neuromuscular diseasesAutonomic nervous system
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Feb 22, 2025
Correction: Anti-IL-5 Pathway Agents in Eosinophilic-Associated Disorders Across the Lifespan.

Carlo Lombardi, Pasquale Comberiati, Erminia Ridolo

|Aug 01, 2024
Correction to: Long-term treatment of hereditary transthyretin amyloidosis with patisiran: multicentre, real-world experience in Italy.

Luca Gentile, Anna Mazzeo, Chiara Briani

|Jun 07, 2024
Anti-IL-5 Pathway Agents in Eosinophilic-Associated Disorders Across the Lifespan.

Carlo Lombardi, Pasquale Comberiati, Erminia Ridolo

|Apr 15, 2024
Long-term treatment of hereditary transthyretin amyloidosis with patisiran: multicentre, real-world experience in Italy.

Luca Gentile, Anna Mazzeo, Chiara Briani

|Apr 13, 2024
Immune-Related Adverse Events Due to Cancer Immunotherapy: Immune Mechanisms and Clinical Manifestations.

Silvia Casagrande, Giulia Boscato Sopetto, Giovanni Bertalot

|Aug 27, 2021
Circulating Biomarkers in Neuromuscular Disorders: What Is Known, What Is New.

Andrea Barp, Amanda Ferrero, Silvia Casagrande

Pageof 2

Frequent Collaborators

3 joint publications

Alvise Berti

2 joint publications

Francesca Forcina

2 joint publications

Marco Bottazzoli

2 joint publications

Marina Grandis